申请人:Hangauer G. David
公开号:US20050176683A1
公开(公告)日:2005-08-11
The present invention relates to tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione derivative compounds, hexahydro-pyrrolo[1,2-a]pyrimidine-2,6-dione derivative compounds, and combinatorial libraries comprising such compounds. The present invention also relates to methods of preparing such compounds. The methods first involve providing a functionalized resin solid support. Next, the functionalized resin solid support is reacted with amino acids under conditions effective to produce a resin bound dipeptide or tripeptide alcohol intermediate compound. Then, the resin bound dipeptide or tripeptide alcohol intermediate compound is oxidized under conditions effective to convert the resin bound dipeptide or tripeptide alcohol intermediate compound to a resin bound dipeptide or tripeptide aldehyde intermediate compound. Finally, the resin bound dipeptide or tripeptide aldehyde intermediate compound is cyclized under conditions effective to produce the tetrahydro-pyrrolo[1,2-a]imidazole-2,5-dione derivative or hexahydro-pyrrolo[1,2-a]pyrimidine-2,6-dione derivative compound. The methods can be performed in solid phase, solid/solution phase, or solution phase.
本发明涉及四氢-吡咯并[1,2-a]咪唑-2,5-二酮衍生物化合物、六氢-吡咯并[1,2-a]嘧啶-2,6-二酮衍生物化合物以及包含此类化合物的组合库。本发明还涉及制备此类化合物的方法。这些方法首先涉及提供功能化树脂固体支持物。接着,在有效的条件下,功能化树脂固体载体与氨基酸反应,生成树脂结合二肽或三肽醇中间体化合物。然后,在有效条件下对树脂结合二肽或三肽醇中间化合物进行氧化,将树脂结合二肽或三肽醇中间化合物转化为树脂结合二肽或三肽醛中间化合物。最后,树脂结合二肽或三肽醛中间体化合物在有效条件下环化,生成四氢吡咯并[1,2-a]咪唑-2,5-二酮衍生物或六氢吡咯并[1,2-a]嘧啶-2,6-二酮衍生物化合物。这些方法可以在固相、固/溶相或溶液相中进行。